Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Finasteride may cause kidney damage.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

The document concludes that effectively managing PCOS requires a multifaceted approach.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

The document concludes that more research is needed to fully understand the causes of PCOS.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.